A detailed history of Thoroughbred Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 21,996 shares of ABBV stock, worth $3.85 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
21,996
Previous 22,671 2.98%
Holding current value
$3.85 Million
Previous $3.89 Million 11.7%
% of portfolio
0.28%
Previous 0.26%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $110,592 - $134,547
-675 Reduced 2.98%
21,996 $4.34 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $516,998 - $603,738
-3,340 Reduced 12.84%
22,671 $3.89 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $94,933 - $108,167
-594 Reduced 2.23%
26,011 $4.74 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $426,284 - $480,097
3,098 Added 13.18%
26,605 $4.12 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $492,145 - $569,730
3,684 Added 18.58%
23,507 $3.5 Million
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $37,235 - $46,336
281 Added 1.44%
19,823 $2.67 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $27,186 - $31,309
-188 Reduced 0.95%
19,542 $3.11 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $23,651 - $28,363
171 Added 0.87%
19,730 $3.19 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $25,231 - $28,938
188 Added 0.97%
19,559 $2.63 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $5,229 - $6,648
38 Added 0.2%
19,371 $2.97 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $319,391 - $396,275
2,420 Added 14.31%
19,333 $3.13 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $98,728 - $124,919
919 Added 5.75%
16,913 $2.29 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $39,687 - $45,050
373 Added 2.39%
15,994 $1.73 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $56,708 - $63,176
539 Added 3.57%
15,621 $1.76 Million
Q1 2021

Apr 30, 2021

BUY
$102.3 - $112.62 $192,221 - $211,612
1,879 Added 14.23%
15,082 $1.63 Million
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $92,241 - $124,535
1,146 Added 9.5%
13,203 $1.41 Million
Q3 2020

Oct 28, 2020

BUY
$85.91 - $100.83 $8,075 - $9,478
94 Added 0.79%
12,057 $1.06 Million
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $91,492 - $122,430
-1,247 Reduced 9.44%
11,963 $1.18 Million
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $12,577 - $19,069
195 Added 1.5%
13,210 $1.01 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $52,654 - $65,882
-730 Reduced 5.31%
13,015 $1.15 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $9,447 - $11,358
-150 Reduced 1.08%
13,745 $1.04 Million
Q2 2019

Jul 16, 2019

SELL
$65.7 - $83.98 $65.5 Million - $83.7 Million
-996,599 Reduced 98.62%
13,895 $0
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $65.5 Million - $83.8 Million
997,472 Added 7659.9%
1,010,494 $0
Q1 2019

May 07, 2019

BUY
$77.14 - $90.79 $42,118 - $49,571
546 Added 4.38%
13,022 $1.05 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $971,256 - $1.2 Million
12,476 New
12,476 $1.15 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.